Valute / CYTK
CYTK: Cytokinetics Incorporated
35.33
USD
2.02
(5.41%)
Il tasso di cambio CYTK ha avuto una variazione del -5.41% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 35.22 e ad un massimo di 37.73.
Segui le dinamiche di Cytokinetics Incorporated. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CYTK News
- Cytokinetics And The 'Provocative Conversation' That Could Rewrite Heart Disease
- Will Camzyos Strengthen BMY's Cardiovascular Portfolio?
- Cytokinetics appoints James M. Daly to board of directors and compliance committee
- Cytokinetics: Specialty Franchise With Aficamten And Ulacamten (NASDAQ:CYTK)
- Cytokinetics appoints James Daly to board of directors
- Cytokinetics, Incorporated (CYTK) Q2 2025 Earnings Call Transcript
- Cytokinetics (CYTK) Reports Q2 Loss, Tops Revenue Estimates
- Cytokinetics shares rise on strong Q2 results
- Cytokinetics Inc earnings beat by $0.30, revenue topped estimates
- Techne (TECH) Beats Q4 Earnings and Revenue Estimates
- Raymond James downgrades Cytokinetics stock rating to Market Perform
- Zymeworks (ZYME) Surges 7.1%: Is This an Indication of Further Gains?
- Cytokinetics (CYTK) CEO Blum sells $190k in stock
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Cytokinetics CEO Robert Blum sells $169,000 in stock
- Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program
- Cytokinetics at Jefferies Conference: Aficamten’s Market Expansion
- Cytokinetics to Participate in the Jefferies Global Healthcare Conference
- Mizuho cuts Cytokinetics stock target to $84 from $103
- Stifel maintains Buy rating and $87 target on Cytokinetics stock
- Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence (NYSE:BMY)
- Cytokinetics at RBC Conference: Strategic Insights on Drug Development
- Tesla’s 2025 Shuffle: Buy the Dip or Dodge the Bullet?
- Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress
Intervallo Giornaliero
35.22
37.73
Intervallo Annuale
29.31
59.39
- Chiusura Precedente
- 37.35
- Apertura
- 37.13
- Bid
- 35.33
- Ask
- 35.63
- Minimo
- 35.22
- Massimo
- 37.73
- Volume
- 8.123 K
- Variazione giornaliera
- -5.41%
- Variazione Mensile
- -5.08%
- Variazione Semestrale
- -22.54%
- Variazione Annuale
- -37.72%
31 agosto, domenica